157 related articles for article (PubMed ID: 21256847)
21. Lipid metabolism in Cryptococcus neoformans.
Shea JM; Henry JL; Del Poeta M
FEMS Yeast Res; 2006 Jun; 6(4):469-79. PubMed ID: 16696643
[TBL] [Abstract][Full Text] [Related]
22. Characterization of additional components of the environmental pH-sensing complex in the pathogenic fungus
Pianalto KM; Ost KS; Brown HE; Alspaugh JA
J Biol Chem; 2018 Jun; 293(26):9995-10008. PubMed ID: 29769315
[TBL] [Abstract][Full Text] [Related]
23. Characterization and regulation of the trehalose synthesis pathway and its importance in the pathogenicity of Cryptococcus neoformans.
Petzold EW; Himmelreich U; Mylonakis E; Rude T; Toffaletti D; Cox GM; Miller JL; Perfect JR
Infect Immun; 2006 Oct; 74(10):5877-87. PubMed ID: 16988267
[TBL] [Abstract][Full Text] [Related]
24. Identification of extracellular phospholipase B, lysophospholipase, and acyltransferase produced by Cryptococcus neoformans.
Chen SC; Wright LC; Santangelo RT; Muller M; Moran VR; Kuchel PW; Sorrell TC
Infect Immun; 1997 Feb; 65(2):405-11. PubMed ID: 9009289
[TBL] [Abstract][Full Text] [Related]
25. Roles for inositol-phosphoryl ceramide synthase 1 (IPC1) in pathogenesis of C. neoformans.
Luberto C; Toffaletti DL; Wills EA; Tucker SC; Casadevall A; Perfect JR; Hannun YA; Del Poeta M
Genes Dev; 2001 Jan; 15(2):201-12. PubMed ID: 11157776
[TBL] [Abstract][Full Text] [Related]
26. ISC1-encoded inositol phosphosphingolipid phospholipase C is involved in Na+/Li+ halotolerance of Saccharomyces cerevisiae.
Betz C; Zajonc D; Moll M; Schweizer E
Eur J Biochem; 2002 Aug; 269(16):4033-9. PubMed ID: 12180980
[TBL] [Abstract][Full Text] [Related]
27. Amino Acid Permeases and Virulence in Cryptococcus neoformans.
Martho KF; de Melo AT; Takahashi JP; Guerra JM; Santos DC; Purisco SU; Melhem MS; Fazioli RD; Phanord C; Sartorelli P; Vallim MA; Pascon RC
PLoS One; 2016; 11(10):e0163919. PubMed ID: 27695080
[TBL] [Abstract][Full Text] [Related]
28. Biochemical properties of mammalian neutral sphingomyelinase 2 and its role in sphingolipid metabolism.
Marchesini N; Luberto C; Hannun YA
J Biol Chem; 2003 Apr; 278(16):13775-83. PubMed ID: 12566438
[TBL] [Abstract][Full Text] [Related]
29. Role and mechanism of phosphatidylinositol-specific phospholipase C in survival and virulence of Cryptococcus neoformans.
Chayakulkeeree M; Sorrell TC; Siafakas AR; Wilson CF; Pantarat N; Gerik KJ; Boadle R; Djordjevic JT
Mol Microbiol; 2008 Aug; 69(4):809-26. PubMed ID: 18532984
[TBL] [Abstract][Full Text] [Related]
30. Unusual effect of myo-inositol on phospholipid biosynthesis in Cryptococcus neoformans.
Vincent VL; Klig LS
Microbiology (Reading); 1995 Aug; 141 ( Pt 8)():1829-1837. PubMed ID: 7551047
[TBL] [Abstract][Full Text] [Related]
31. Cryptococcus neoformans Cda1 and Its Chitin Deacetylase Activity Are Required for Fungal Pathogenesis.
Upadhya R; Baker LG; Lam WC; Specht CA; Donlin MJ; Lodge JK
mBio; 2018 Nov; 9(6):. PubMed ID: 30459196
[TBL] [Abstract][Full Text] [Related]
32. An overview of sphingolipid metabolism: from synthesis to breakdown.
Gault CR; Obeid LM; Hannun YA
Adv Exp Med Biol; 2010; 688():1-23. PubMed ID: 20919643
[TBL] [Abstract][Full Text] [Related]
33. Isc1 regulates sphingolipid metabolism in yeast mitochondria.
Kitagaki H; Cowart LA; Matmati N; Vaena de Avalos S; Novgorodov SA; Zeidan YH; Bielawski J; Obeid LM; Hannun YA
Biochim Biophys Acta; 2007 Nov; 1768(11):2849-61. PubMed ID: 17880915
[TBL] [Abstract][Full Text] [Related]
34. Enzymatic characterization of clinical and environmental Cryptococcus neoformans strains isolated in Italy.
Pini G; Faggi E; Campisi E
Rev Iberoam Micol; 2017; 34(2):77-82. PubMed ID: 28215482
[TBL] [Abstract][Full Text] [Related]
35. The Transcription Factor Pdr802 Regulates Titan Cell Formation and Pathogenicity of Cryptococcus neoformans.
Reuwsaat JCV; Agustinho DP; Motta H; Chang AL; Brown H; Brent MR; Kmetzsch L; Doering TL
mBio; 2021 Mar; 12(2):. PubMed ID: 33688010
[No Abstract] [Full Text] [Related]
36.
Chitty JL; Blake KL; Blundell RD; Koh YQAE; Thompson M; Robertson AAB; Butler MS; Cooper MA; Kappler U; Williams SJ; Kobe B; Fraser JA
J Biol Chem; 2017 Jul; 292(28):11829-11839. PubMed ID: 28559277
[TBL] [Abstract][Full Text] [Related]
37. Unraveling the novel structure and biosynthetic pathway of O-linked glycans in the Golgi apparatus of the human pathogenic yeast Cryptococcus neoformans.
Lee DJ; Bahn YS; Kim HJ; Chung SY; Kang HA
J Biol Chem; 2015 Jan; 290(3):1861-73. PubMed ID: 25477510
[TBL] [Abstract][Full Text] [Related]
38. Integrated Activity and Genetic Profiling of Secreted Peptidases in Cryptococcus neoformans Reveals an Aspartyl Peptidase Required for Low pH Survival and Virulence.
Clarke SC; Dumesic PA; Homer CM; O'Donoghue AJ; La Greca F; Pallova L; Majer P; Madhani HD; Craik CS
PLoS Pathog; 2016 Dec; 12(12):e1006051. PubMed ID: 27977806
[TBL] [Abstract][Full Text] [Related]
39. Zinc Finger Proteins in the Human Fungal Pathogen
Li YH; Liu TB
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32085473
[TBL] [Abstract][Full Text] [Related]
40. Identification and characterization of an SKN7 homologue in Cryptococcus neoformans.
Wormley FL; Heinrich G; Miller JL; Perfect JR; Cox GM
Infect Immun; 2005 Aug; 73(8):5022-30. PubMed ID: 16041017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
